Systemic chemotherapy in patients with peritoneal carcinomatosis from non colorectal origin

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 441-448

  Van Lierde, Sybile ^a   Denys, Hannelore ^a   Peeters, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CARCINOMA; HUMAN; METASTASIS; PERITONEUM TUMOR; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; HUMANS; PERITONEAL NEOPLASMS;

EID: 34548413734     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_29     Document Type: Chapter

References (32)

1. Truong LD, Maccato ML, Awalt H, Cagle PT, Schwarts MR, Kaplan AL. (1990) Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol 1990;21:99-110
2. White CD. (1993) Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries. W V Med J 89:282-283
3. Shah IA, Jayram L, Gani OS, Fox IS, Stanley TM. (1998) Papillary serous carcinoma of the peritoneum in a man. A case report. Cancer 82:860-866
4. Swerdlow M. (1959) Mesothelioma of the pelvic peritoneum reassembly papillary cystadenocarcinoma of the ovary: case report. Am J Obstet Gynecol 77:197-200
5. Dalrymple JC, Bannatyne P, Russell HJ, Solomon HJ, Tattersall MHN, Atkinson K, et al. (1989) Extraovarian peritoneal serous papillary carcinoma: a clinicopathological study of 31 cases. Cancer 64:110-115
6. Ranson DT, Shreyaskumar RP, Keeney GL, Malkasian GD, Edmonson JH. (1990) Papillary serous carcinoma of the peritoneum. Cancer 1990;66:1091-4
7. Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol 75:75-89
8. Lele SB, Piver MJ, Matharu J, Tsukadu Y. (1988) Peritoneal papillary carcinoma. Gynecol Oncol 31:315-320
9. Bloss JD, Shu-Yuan L, Buller RE, Manetta A, Berman ML, MC-Meekin S, et al. (1993) Extraovarian peritoneal serous papillary carcinoma: a casecontrol retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50:347-351
10. Therasse P, Arbuck SG, Eisenhauer EA, et al. (2000) New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
11. Stafford-Johnson DB, Bree RL, Francis IR, Korobkin M. (1998) CT appearance of primary papillary serous carcinoma of the peritoneum. AJR Am J Roentgenol 171:687-689
12. Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. (1998) Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst 90(11):797-799
13. Minsky BD, Mies C, Rich TA, et al. (1988) Potentially curative surgery of colon cancer : Patterns of failure and survival. J Clin Oncol 6:106-118
14. Sugarbaker PH. (1988) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254-261
15. Warhol MS, Hunter NJ, Corson JM. (1982) An ultrastructural comparison of mesotheliomas and adenocarcinoma of the ovary and endometrium. Int J Gynecol Pathol (1982) 1:125-134
16. Rezkalla MA, Peterson KG, Ryan JJ. (2006) Pseudomyxoma peritonei: a case of mucinous adenocarcinoma of the appendix presenting as inguinal hernia. S D Med 59:54-5,57
17. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Patridge EE, Look KY, Clarke-Pearson DL, Davidson M. (1996) Cyclophosphamide and cisplatin compared with paclitaxel in patients with stage III and IV ovarian cancer. N Engl J Med 334:1-6
18. Parmer MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, et al. ICON and AGO Collaborators. (2003) Paclitaxel plus platinumbased chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 21:2099-2106
19. Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, Stuart G, Jiang C, Markman M, Alberts DS. (2003) Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial. J Clin Oncol 21:1313-1319
20. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group. (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34-43
21. Raju U, Fine G, Greenwald KA, Ohrodnik JM. (1989) Primary papillary serous neoplasia of the peritoneum: A clinicopathologic and ultrastructural study of eight cases. Hum Pathol 20:426-436
22. Bloss JD, Brady MF, Shu Yaun Liau, Rocereto T, Partridge EE, Clarke- Pearson DL. (2003) Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma- a Gynecologic Oncology Group Study. 89:148-154
23. Ayhan A, Taskiran C, Yigit-Celik N, Bozdag G, Gultekin M, Usubutun A, Guler N, Yuce K. (2006) Long-term survival after paclitaxel plus platinumbased combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Int J Gynecol Cancer 16:484-489
24. Scully RE. (1998) The Eltabbakh/Piver article reviewed. Oncology 12:820-825
25. Nam JH, Kim YM, Jung MH, et al. (2006) Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. Int J Gynecol Cancer 16:23-28
26. Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE. (1997) Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol 67:141-146
27. Sugarbaker PH, Chang D. (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727-731
28. Witkamp AJ, de Bree E, Kaag MM, et al. (2001) Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycine-C in patients with peritoneal carcinomatosis of colorectal origine. Eur J Cancer 37:979-984
29. Verwaal VJ, van Ruth S, de Bree E, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743
30. Laufman LR, Krzeczowski KA, Roach R, et al. (1987) Leucovorin plus 5- fluorouracil: An effective treatment for metastatic colon cancer. J Clin Oncol 5:1394-1400
31. Andre T, Louvet C, Maindrault-Goebel F, et al. (1999) CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer - GERCOR. Eur J Cancer 35:1343-1347
32. De Gramont A, Figer A, Seymour M, et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947